Determining Small Molecule Inhibitors of Calpain To Promote Cholesterol Efflux in Macrophage-Derived Foam Cells
ISEF · 2025 Biomedical and Health Sciences Fourth Award
Overview
Heart disease is the leading cause of death for both men and women in the United States, and is responsible for a third of deaths worldwide. Most cardiovascular disease is caused by the accumulation of plaque in the artery walls, otherwise known as atherosclerosis. When cholesterol settles into the wall of the artery, macrophages migrate to the area and trap the cholesterol, becoming foam cells and creating plaques. One of the primary proteins involved in the cholesterol influx process is calpain, an intracellular calcium dependent protease. Molecular docking was used to identify a top small molecule inhibitor of calpain which should promote cholesterol efflux from cells and reduce foam cell formation. Among a variety of atheroprotective compounds that were screened, quercetin was found to be a top performing compound, with an average binding affinity of -64.826 kcal/mol. An Amplex Red Cholesterol Assay was used to quantify cholesterol efflux from lipid laden J774a.1 macrophage-like cells, treated with 100uM of quercetin. These values will then be compared against piperine (50 uM), which is known to improve cholesterol efflux capabilities. The results of the Amplex Red showed that the foam cells treated with quercetin had a higher level of cholesterol efflux in comparison to piperine. More trials will be run, and a Western blot for an associated protein (CD36) will be done. Data collection is ongoing.
Awards (1)
- Fourth Award of $600 $600
Competition history
- ISEF 2025
Resources
Related projects
CSEF · 2015
Using Virtual Screening Methods to Identify a Novel and Noninvasive Method of Heart Disease Treatment and Prevention
ISEF · 2015
Using Virtual Screening Methods to Identify a Novel and Noninvasive Method of Heart Disease Treatment and Prevention
ISEF · 2016
New Approach to Prevent Monocyte Dysfunction Associated with Metabolic Diseases
JSHS · 2023
Creation and Simulation of Function of Claramine-Atorvastatin Coated Hyaluronic Acid Nanoparticles for Targeted Dissolution of Atherosclerotic Plaque
AJAS · 2022
Epigenetic Engineering in Immune Cells Prevents Disease Mechanisms in Atherosclerosis
ISEF · 2024
Preclinical Investigation to Develop Anti-Platelet and Cholesterol-Lowering Agent for Prevention and Treatment of Stroke
ISEF · 2015
Nanoparticle-Induced Macrophage Atherogenesis
CSEF · 2017
Biocompatible Microdroplets: A Paradigm Shift in the Reversal of Atherosclerosis
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair